ɬŔď·¬

Journal News

How flame retardants could impair neurodevelopment

Anna Tancredi
Dec. 24, 2020

Evidence has been mounting for years that the flame retardants coating our furniture, electronics and construction materials are more harmful than helpful to human health. Members of one class of these retardants, polybrominated diphenyl ethers, or PBDEs, have come under increased scrutiny for their potential role in disrupting neurodevelopment, especially in children. Researchers have found that the 209 PBDE congeners can bioaccumulate in lipid-rich tissues, including in the brain, but the precise mechanism by which these compounds cause harm remains unknown.

Ramendra Saha, who effective Jan. 1 will be an associate professor of cellular and molecular biology at the University of California, Merced, first heard about PBDEs at the National Institute of Environmental Sciences, where he was a postdoctoral fellow. He listened to speaker after speaker describe the potential toxicity of these compounds that seemed to litter every home. As a new father at the time, he wondered how he could keep his son safe.

Armed with a background in neuroplasticity and transcription, Saha delved into the epigenetic effects of PBDEs in neuronal development and function.

Saha's lab found that certain PBDEs can act as promiscuous kinase inhibitors and disrupt a signaling pathway involved in cell growth, division and differentiation known as the mitogen-activated protein kinase extracellular signal-regulated kinase, or MEK–ERK, pathway.

"We were looking at environmental toxins that have been shown to have some correlation with intellectual disability and that act as an inhibitor to signaling cascades that are known to be important to normal neurodevelopment," Saha explained.

A paper in the Journal of Biological Chemistry describes the study in which Saha's team proposed a new mechanism by which one particularly toxic PBDE, 6-OH-BDE-47, known as 6-OH, could impair the MEK–ERK signaling pathway. Robert Poston, a Ph.D. student in Saha's lab at the time, noticed that MEK inhibitor PD0325901, or PD, had key chemical structures similar to 6-OH. Using 3D modeling software, the researchers simulated the binding interactions of both 6-OH and PD with MEK1.

The results were encouraging: 6-OH and PD both were calculated to bind in the same allosteric binding site for MEK1. When they tried to demonstrate this binding directly in the lab, however, they were stumped: Increasing amounts of 6-OH added to MEK1 did not lower MEK1 activity.

Teaming up with researchers at the University of Dundee in Scotland, they screened 6-OH with 140 kinases that represent most of the human kinome. Simulations of their top hits showed that 6-OH binding was most likely in the well-known ATP-binding pockets of the screened kinases, suggesting this PBDE could be a promiscuous ATP-competitive kinase inhibitor and could explain the complex and diverse effects of PBDE exposure.

Saha's group continues to study how 6-OH exposure can affect mitochondrial function, calcium homeostasis, regulation of synaptic function and other links to the impairment of MEK–ERK signaling.

Has Saha's work in the toxicology field changed his family's behavior? "Absolutely," he said. "We do not buy anything that is labeled 'fire resistant.'"

Though we might not be able to avoid PBDEs completely in items such as laptop computers, Saha suggests replacing old furniture and paying attention to consumer item labels to minimize exposure.

Saha-kinase-890x332.jpg
Poston et al. 2020
Ligand-docking simulation results for the top three hits from the kinase screen. Crystal structures were obtained from the Protein Data Bank, and Autodock-Vina was used to find energetically optimal binding poses for 6-OH (red) with each kinase. Top binding poses clustered largely to the well-known ATP-binding pockets of the kinases. 6-OH acting as an ATP-competitive kinase inhibitor may help to explain the complex and diverse effects documented for PBDE exposures.

Enjoy reading ASBMB Today?

Become a member to receive the print edition four times a year and the digital edition monthly.

Learn more
Anna Tancredi

Anna Tancredi received a bachelor's degree in molecular biology from Kenyon College.

Get the latest from ASBMB Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Top reviewers at ASBMB journals
Observance

Top reviewers at ASBMB journals

Sept. 19, 2025

Editors recognize the heavy-lifters and rising stars during Peer Review Week.

Teaching AI to listen
Essay

Teaching AI to listen

Sept. 18, 2025

A computational medicine graduate student reflects on building natural language processing tools that extract meaning from messy clinical notes — transforming how we identify genetic risk while redefining what it means to listen in science.

Early lipid changes drive retinal degeneration in Zellweger spectrum disorder
Journal News

Early lipid changes drive retinal degeneration in Zellweger spectrum disorder

Sept. 16, 2025

Lipid profiling in a rare disease mouse model reveals metabolic shifts and inflammation in the retinal pigment epithelium — offering promising biomarker leads to combat blindness.

How sugars shape Marfan syndrome
Journal News

How sugars shape Marfan syndrome

Sept. 10, 2025

Research from the University of Georgia shows that Marfan syndrome–associated fibrillin-1 mutations disrupt O glycosylation, revealing unexpected changes that may alter the protein's function in the extracellular matrix.

What’s in a diagnosis?
Essay

What’s in a diagnosis?

Sept. 4, 2025

When Jessica Foglio’s son Ben was first diagnosed with cerebral palsy, the label didn’t feel right. Whole exome sequencing revealed a rare disorder called Salla disease. Now Jessica is building community and driving research for answers.

Peer through a window to the future of science
Annual Meeting

Peer through a window to the future of science

Sept. 3, 2025

Aaron Hoskins of the University of Wisconsin–Madison and Sandra Gabelli of Merck, co-chairs of the 2026 ASBMB annual meeting, to be held March 7–10, explain how this gathering will inspire new ideas and drive progress in molecular life sciences.